Zhu et al. [45] reported that TQ inhibited pulmonary arterial remodeling through the P38MAPK/NF-κB signaling pathway and showed a partially therapeutic effect on induced pulmonary arterial hypertension in rats. This evidence concerns the gene NFKB1 and pulmonary arterial hypertension.